Skip to main content
Top
Published in: Neurological Sciences 7/2019

01-07-2019 | Multiple Sclerosis | Original Article

Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study

Authors: Pasquale Annunziata, Gianni Masi, Chiara Cioni, Matteo Gastaldi, Enrico Marchioni, Emanuele D’amico, Francesco Patti, Alice Laroni, Gianluigi Mancardi, Francesca Vitetta, Patrizia Sola

Published in: Neurological Sciences | Issue 7/2019

Login to get access

Abstract

Objectives

We compared the clinical, laboratory, and radiological features of different subgroups of acute transverse myelitis (ATM) diagnosed according to the criteria established by the Transverse Myelitis Consortium Working Group (TMCWG) as well as of non-inflammatory acute transverse myelopathies (NIATM) to identify possible short- and long-term prognostic factors.

Methods

A multicenter and retrospective study comprising 110 patients with ATM and 15 NIATM admitted to five Italian neurological units between January 2010 and December 2014 was carried out.

Results

A significantly higher frequency of isolated sensory disturbances at onset in ATM than in NIATM patients (chi-square = 14. 7; P = 0.005) and a significantly higher frequency of motor symptoms in NIATM than ATM (chi-square = 12.4; P = 0.014) was found. ATM patients with high disability at discharge had more motor-sensory symptoms without (OR = 3.87; P = 0.04) and with sphincter dysfunction at onset (OR = 7.4; P = 0.0009) compared to those with low disability. Higher age (OR = 1.08; P = 0.001) and motor-sensory-sphincter involvement at onset (OR = 9.52; P = 0.002) were significantly associated with a high disability score at discharge and after a median 1-year follow-up.

Conclusions

The diagnosis of ATM may prevail respect to that of NIATM when a sensory symptomatology at onset occurs. In ATM, patients older and with motor-sensory involvement with or without sphincter impairment at admission could experience a major risk of poor prognosis both at discharge and at longer time requiring a timely and more appropriate treatment.
Appendix
Available only for authorised users
Literature
2.
go back to reference Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499–505CrossRef Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499–505CrossRef
3.
go back to reference Ropper AH, Poskanzer DC (1978) The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 4:51–59CrossRefPubMed Ropper AH, Poskanzer DC (1978) The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 4:51–59CrossRefPubMed
4.
go back to reference Berman M, Feldman S, Alter M, Zilber N, Kahana E (1981) Acute transverse myelitis: incidence and etiologic considerations. Neurology 31:966–971CrossRefPubMed Berman M, Feldman S, Alter M, Zilber N, Kahana E (1981) Acute transverse myelitis: incidence and etiologic considerations. Neurology 31:966–971CrossRefPubMed
5.
go back to reference Jeffery DR, Mandler RN, Davis LE (1993) Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50:532–535CrossRefPubMed Jeffery DR, Mandler RN, Davis LE (1993) Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50:532–535CrossRefPubMed
6.
go back to reference Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed
7.
go back to reference Gajofatto A, Monaco S, Fiorini M et al (2010) Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Arch Neurol 67:724–730CrossRefPubMed Gajofatto A, Monaco S, Fiorini M et al (2010) Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Arch Neurol 67:724–730CrossRefPubMed
8.
go back to reference Gastaldi M, Marchioni E, Banfi P, Mariani V, di Lodovico L, Bergamaschi R, Alfonsi E, Borrelli P, Ferraro OE, Zardini E, Pichiecchio A, Cortese A, Waters P, Woodhall M, Ceroni M, Mauri M, Franciotta D (2018) Predictors of outcome in a large retrospective cohort of patients with transverse myelitis. Mult Scler 24:1743–1752CrossRefPubMed Gastaldi M, Marchioni E, Banfi P, Mariani V, di Lodovico L, Bergamaschi R, Alfonsi E, Borrelli P, Ferraro OE, Zardini E, Pichiecchio A, Cortese A, Waters P, Woodhall M, Ceroni M, Mauri M, Franciotta D (2018) Predictors of outcome in a large retrospective cohort of patients with transverse myelitis. Mult Scler 24:1743–1752CrossRefPubMed
9.
go back to reference De Seze J, Lanctin C, Lebrun C et al (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65:1950–1953CrossRefPubMed De Seze J, Lanctin C, Lebrun C et al (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65:1950–1953CrossRefPubMed
10.
go back to reference Bruna J, Martínez-Yélamos S, Martínez-Yélamos A, Rubio F, Arbizu T (2006) Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 12:169–173CrossRefPubMed Bruna J, Martínez-Yélamos S, Martínez-Yélamos A, Rubio F, Arbizu T (2006) Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 12:169–173CrossRefPubMed
12.
go back to reference Lipton HL, Teasdall RD (1973) Acute transverse myelopathy in adults. A follow-up study. Arch Neurol 28:252–257CrossRefPubMed Lipton HL, Teasdall RD (1973) Acute transverse myelopathy in adults. A follow-up study. Arch Neurol 28:252–257CrossRefPubMed
13.
go back to reference Christensen PB, Wermuth L, Hinge HH, Bømers K (1990) Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 81:431–435CrossRefPubMed Christensen PB, Wermuth L, Hinge HH, Bømers K (1990) Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 81:431–435CrossRefPubMed
14.
go back to reference Misra UK, Kalita J, Kumar S (1996) A clinical, MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci 138:150–156CrossRefPubMed Misra UK, Kalita J, Kumar S (1996) A clinical, MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci 138:150–156CrossRefPubMed
15.
go back to reference Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG, International Panel for NMO Diagnosis (2015) International diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189CrossRefPubMedPubMedCentral Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG, International Panel for NMO Diagnosis (2015) International diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189CrossRefPubMedPubMedCentral
16.
go back to reference Farrell B, Godwin J, Richards S, Warlow C (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54:1044–1054CrossRefPubMedPubMedCentral Farrell B, Godwin J, Richards S, Warlow C (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54:1044–1054CrossRefPubMedPubMedCentral
17.
go back to reference Scott TF (2007) Nosology of idiopathic transverse myelitis syndromes. Acta Neurol Scand 115:371–376CrossRefPubMed Scott TF (2007) Nosology of idiopathic transverse myelitis syndromes. Acta Neurol Scand 115:371–376CrossRefPubMed
18.
go back to reference Miller DH, Ormerod IE, Rudge P, Kendall BE, Moseley IF, McDonald WI (1989) The early risk ofmultiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 26:635–639CrossRefPubMed Miller DH, Ormerod IE, Rudge P, Kendall BE, Moseley IF, McDonald WI (1989) The early risk ofmultiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 26:635–639CrossRefPubMed
19.
go back to reference De Seze J, Stojkovic T, Breteau G et al (2001) Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 124:1509–1521CrossRefPubMed De Seze J, Stojkovic T, Breteau G et al (2001) Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 124:1509–1521CrossRefPubMed
20.
go back to reference Harzeim M, Schlegel U, Urbach H, Klockgether T, Schmidt S (2004) Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 217:217–223CrossRef Harzeim M, Schlegel U, Urbach H, Klockgether T, Schmidt S (2004) Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 217:217–223CrossRef
21.
go back to reference Campi A, Filippi M, Comi G (1995) Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. Am J Neuroradiol 16:115–123PubMedPubMedCentral Campi A, Filippi M, Comi G (1995) Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. Am J Neuroradiol 16:115–123PubMedPubMedCentral
22.
go back to reference Marti-Fabregas J, Martinez JM, Illa I, Escartin A (1989) Myelopathy of unknown origin. Acta Neurol Scand 80:455–460CrossRefPubMed Marti-Fabregas J, Martinez JM, Illa I, Escartin A (1989) Myelopathy of unknown origin. Acta Neurol Scand 80:455–460CrossRefPubMed
23.
go back to reference Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566–569CrossRefPubMed Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566–569CrossRefPubMed
24.
go back to reference Scott TF, Kassab S, Pittock SJ (2006) Neuromyelitis optica antibodies and acute partial transverse myelitis. Arch Neurol 63:1398–1400CrossRefPubMed Scott TF, Kassab S, Pittock SJ (2006) Neuromyelitis optica antibodies and acute partial transverse myelitis. Arch Neurol 63:1398–1400CrossRefPubMed
25.
go back to reference Bakshi R, Kinkel PR, Mechtler LL, Bates VE, Lindsay BD, Esposito SE, Kinkel WR (1998) Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patient with and without multiple sclerosis. Eur J Neurol 5:35–48CrossRefPubMed Bakshi R, Kinkel PR, Mechtler LL, Bates VE, Lindsay BD, Esposito SE, Kinkel WR (1998) Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patient with and without multiple sclerosis. Eur J Neurol 5:35–48CrossRefPubMed
26.
go back to reference Cobo Calvo A, Mañé Martínez MA, Alentorn-Palau A, Bruna Escuer J, Romero Pinel L, Martínez-Yélamos S (2013) Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series. BMC Neurol 13:135CrossRefPubMedPubMedCentral Cobo Calvo A, Mañé Martínez MA, Alentorn-Palau A, Bruna Escuer J, Romero Pinel L, Martínez-Yélamos S (2013) Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series. BMC Neurol 13:135CrossRefPubMedPubMedCentral
27.
28.
go back to reference Kim KK (2003) Idiopathic recurrent transverse myelitis. Arch Neurol 60:1290–1294PubMed Kim KK (2003) Idiopathic recurrent transverse myelitis. Arch Neurol 60:1290–1294PubMed
29.
go back to reference Hummers LK, Krishnan C, Casciola-Rosen L, Rosen A, Morris S, Mahoney JA, Kerr DA, Wigley FM (2004) Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 62:147–149CrossRefPubMed Hummers LK, Krishnan C, Casciola-Rosen L, Rosen A, Morris S, Mahoney JA, Kerr DA, Wigley FM (2004) Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 62:147–149CrossRefPubMed
30.
go back to reference Irani DN, Kerr DA (2000) 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 355:901CrossRefPubMed Irani DN, Kerr DA (2000) 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 355:901CrossRefPubMed
31.
go back to reference De Seze J, Peoc’h K, Ferriby D, Stojkovic T, Laplanche JL, Vermersch P (2002) 14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis. J Neurol 249:626–627CrossRefPubMed De Seze J, Peoc’h K, Ferriby D, Stojkovic T, Laplanche JL, Vermersch P (2002) 14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis. J Neurol 249:626–627CrossRefPubMed
32.
go back to reference Young J, Quinn S, Hurrell M, Taylor B (2009) Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler 15:1295–1302CrossRefPubMed Young J, Quinn S, Hurrell M, Taylor B (2009) Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler 15:1295–1302CrossRefPubMed
Metadata
Title
Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study
Authors
Pasquale Annunziata
Gianni Masi
Chiara Cioni
Matteo Gastaldi
Enrico Marchioni
Emanuele D’amico
Francesco Patti
Alice Laroni
Gianluigi Mancardi
Francesca Vitetta
Patrizia Sola
Publication date
01-07-2019
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 7/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-03830-6

Other articles of this Issue 7/2019

Neurological Sciences 7/2019 Go to the issue